• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Pharmacy-led switches of 5-ASA: impact on secondary care.由药房主导的5-氨基水杨酸转换：对二级医疗的影响
Frontline Gastroenterol. 2013 Apr;4(2):88-90. doi: 10.1136/flgastro-2012-100210. Epub 2012 Nov 12.
2
Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.溃疡性结肠炎和克罗恩病女性的分娩结局以及抗炎药物治疗的药物流行病学方面
Dan Med Bull. 2011 Dec;58(12):B4360.
3
[5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl)].5-氨基水杨酸在溃疡性结肠炎和克罗恩病中的应用（作者译）
Dtsch Med Wochenschr. 1982 Jul 23;107(29-30):1131-4. doi: 10.1055/s-2008-1070088.
4
Oral 4-aminosalicylic acid versus 5-aminosalicylic acid slow release tablets. Double blind, controlled pilot study in the maintenance treatment of Crohn's ileocolitis.口服4-氨基水杨酸与5-氨基水杨酸缓释片。克罗恩氏回结肠炎症维持治疗的双盲对照试验性研究。
Gut. 1994 Aug;35(8):1081-5. doi: 10.1136/gut.35.8.1081.
5
Pharmacokinetics of a 5-aminosalicylic acid enteric-coated tablet in patients with Crohn's disease or ulcerative colitis and in healthy volunteers.5-氨基水杨酸肠溶片在克罗恩病或溃疡性结肠炎患者及健康志愿者体内的药代动力学
Aliment Pharmacol Ther. 1990 Oct;4(5):497-505. doi: 10.1111/j.1365-2036.1990.tb00496.x.
6
Paediatric inflammatory bowel disease in New Zealand.新西兰的儿童炎症性肠病
N Z Med J. 2008 Oct 3;121(1283):19-34.
7
Newer pharmacologic agents for the therapy of inflammatory bowel disease.用于治疗炎症性肠病的新型药物制剂
Med Clin North Am. 1990 Jan;74(1):133-53. doi: 10.1016/s0025-7125(16)30591-0.
8
Steady-state pharmacokinetics of enteric coated 5-amino-salicylic acid tablets in healthy volunteers and in patients with Crohn's disease or ulcerative colitis.肠溶包衣5-氨基水杨酸片在健康志愿者以及克罗恩病或溃疡性结肠炎患者中的稳态药代动力学。
Aliment Pharmacol Ther. 1991 Jun;5(3):291-300. doi: 10.1111/j.1365-2036.1991.tb00030.x.
9
Minimal renal dysfunction in inflammatory bowel disease is related to disease activity but not to 5-ASA use.炎症性肠病中的轻度肾功能不全与疾病活动有关，但与使用5-氨基水杨酸无关。
Aliment Pharmacol Ther. 2001 Mar;15(3):363-9. doi: 10.1046/j.1365-2036.2001.00940.x.
10
Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease.炎症性肠病患者幽门螺杆菌感染率的评估。
Eur J Gastroenterol Hepatol. 2000 Apr;12(4):439-43. doi: 10.1097/00042737-200012040-00012.

引用本文的文献

1
Maintaining stable symptom control in inflammatory bowel disease: a retrospective analysis of adherence, medication switches and the risk of relapse.维持炎症性肠病症状的稳定控制：一项回顾性分析药物依从性、药物转换与复发风险的研究。
Aliment Pharmacol Ther. 2013 Sep;38(5):531-8. doi: 10.1111/apt.12396. Epub 2013 Jul 8.

本文引用的文献

1
European evidence-based Consensus on the management of ulcerative colitis: Current management.欧洲溃疡性结肠炎管理循证共识：当前管理措施
J Crohns Colitis. 2008 Mar;2(1):24-62. doi: 10.1016/j.crohns.2007.11.002. Epub 2008 Jan 18.
2
Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey.炎症性肠病对生活质量的影响：欧洲克罗恩病和溃疡性结肠炎协会（EFCCA）患者调查结果。
J Crohns Colitis. 2007 Sep;1(1):10-20. doi: 10.1016/j.crohns.2007.06.005.
3
What happens to patients who have their asthma device switched without their consent?那些未经其同意就更换哮喘治疗设备的患者会怎样？
Prim Care Respir J. 2010 Jun;19(2):131-9. doi: 10.4104/pcrj.2010.00009.
4
Antiepileptic drugs: the drawbacks of generic substitution.
Lancet Neurol. 2010 Mar;9(3):227. doi: 10.1016/S1474-4422(10)70044-2.
5
Management of stress in inflammatory bowel disease: a therapeutic option?炎症性肠病的应激管理：一种治疗选择？
Expert Rev Gastroenterol Hepatol. 2009 Dec;3(6):661-79. doi: 10.1586/egh.09.55.
6
Understanding patients' perspective in the use of generic antiepileptic drugs: compelling lessons for physicians to improve physician/patient communication.了解患者使用通用抗癫痫药物的观点：给医生改善医患沟通的深刻启示。
BMC Neurol. 2009 Mar 17;9:11. doi: 10.1186/1471-2377-9-11.
7
Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease.炎症性肠病患者对药物的态度及维持治疗的依从性
Inflamm Bowel Dis. 2009 Jun;15(6):837-44. doi: 10.1002/ibd.20846.
8
Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies.5-氨基水杨酸的使用对结直肠癌和发育异常风险的影响：观察性研究的系统评价和荟萃分析
Am J Gastroenterol. 2005 Jun;100(6):1345-53. doi: 10.1111/j.1572-0241.2005.41442.x.
9
The fight for 'health-related normality': a qualitative study of the experiences of individuals living with established inflammatory bowel disease (ibd).为“与健康相关的正常状态”而战：对患有确诊炎症性肠病（IBD）个体经历的定性研究
J Health Psychol. 2005 May;10(3):443-55. doi: 10.1177/1359105305051433.
10
Review article: Oral, modified-release mesalazine formulations--proprietary versus generic.综述文章：口服缓释美沙拉嗪制剂——专利药与仿制药对比
Aliment Pharmacol Ther. 2003 May 15;17(10):1207-14. doi: 10.1046/j.1365-2036.2003.01578.x.

Pharmacy-led switches of 5-ASA: impact on secondary care.

作者信息

Healey Chris J, O'Malley John

机构信息

Gastroenterology and Hepatology Services, Airedale General Hospital, Keighley, West Yorkshire, UK.

Department of Gastroenterology, Wirral University Hospital Trust, Wirral, UK.

出版信息

Frontline Gastroenterol. 2013 Apr;4(2):88-90. doi: 10.1136/flgastro-2012-100210. Epub 2012 Nov 12.

DOI:10.1136/flgastro-2012-100210
PMID:28839706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5369795/
Abstract
摘要